Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-10-24

FDA Approved: NYSTATIN AND TRIAMCINOLONE ACETONIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved Glenmark's Nystatin and Triamcinolone Acetonide as an Original Application (ANDA) for a topical combination product indicated for inflammatory fung…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nystatin and Triamcinolone Acetonide (Nystatin and Triamcinolone Acetonide)

Snippet

ORIG AP for NYSTATIN AND TRIAMCINOLONE ACETONIDE (NYSTATIN AND TRIAMCINOLONE ACETONIDE)